News

Exam-room posters cut inappropriate antibiotics prescriptions

View on the News

Will 'nudge' be sustainable?

Dr. Meeker and her colleagues have developed a novel intervention "based on a sophisticated understanding of how to overcome the psychology that drives behavior linked to inappropriate antibiotic prescription," and it required no complex algorithms, no special technology, no infrastructure, and no enforcement, observed Dr. Brad Spellberg.

"Rather than direct confrontation with the force of education or nagging, they sought a gentler ‘nudging’ approach that worked harmoniously with the underlying psychology of both patient and clinician," he noted.

It remains to be seen whether "this gentle nudge approach" can be generalized to other clinical practices across the country, he added, and whether its effectiveness will be sustained over the long term.

Dr. Spellberg is in the division of general internal medicine at Harbor-UCLA Medical Center and the Los Angeles Biomedical Research Institute in Torrance, Calif. His work is supported by the National Institute of Allergy and Infectious Diseases, and he reported ties to Abbott, Adenium, aRigen, Cardeas, Cempra, GlaxoSmithKline, Meiji, Novan, Pfizer, and Synthetic Biologics. These comments were taken from his invited commentary accompanying Dr. Meeker’s report (JAMA Intern. Med. 2014 [doi:10.1001/jamainternmed.2013.14019]).


 

FROM JAMA INTERNAL MEDICINE

The intervention, based on a psychological principle, was more effective at curtailing inappropriate prescription of antibiotics than are many others currently in use. Those others typically are based on a model holding that clinicians will change their behavior simply because it makes rational sense to do so, and they use techniques such as education, awareness training, electronic alerts or reminders, and financial incentives, the researchers explained.

"[Our] findings support an alternative model suggesting that clinicians are influenced by interpersonal factors within the context of patient care – in particular, a desire to remain consistent with a prior public commitment," Dr. Meeker and her associates said.

They added that their study was limited because it covered a relatively small geographic area, involved a small number of clinicians, and was of short duration. Moreover, even though the intervention succeeded in reducing inappropriate prescribing significantly, the rate of inappropriate prescribing still remained high among the study participants.

The National Institutes of Health and the National Institute on Aging funded the study. Dr. Meeker and her associates reported no relevant financial conflicts of interest.

Pages

Recommended Reading

Multiple antiepileptic drugs may pose risk of aseptic meningitis
MDedge Internal Medicine
Triple-antiviral therapy achieves 94% response without interferon, ribavirin
MDedge Internal Medicine
Dental infection didn’t raise rheumatoid arthritis risk
MDedge Internal Medicine
New agent shortened HSV-2 shedding
MDedge Internal Medicine
Daclatasvir-sofosbuvir combo scores in resistant hepatitis C
MDedge Internal Medicine
Oseltamivir suspension back in production
MDedge Internal Medicine
The price and cost of hepatitis C treatment
MDedge Internal Medicine
What Matters: Bacterial vaginosis
MDedge Internal Medicine
Zinc for colds
MDedge Internal Medicine
Fatal U.S. dengue fever case misdiagnosed as West Nile virus
MDedge Internal Medicine